Elyssa Rubin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elyssa Rubin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amit Soni
Division of Hematology, CHOC Children's Hospital, 1201 W. La Veta Avenue, Orange, CA, 92868, USA
1 shared publication - David Buchbinder
Division of Hematology Children's Hospital of Orange County Orange California USA
1 shared publication - David Margolis
Bone Marrow Transplantation Children's Hospital of Wisconsin Wauwatosa WI USA
1 shared publication - Diane Nugent
Department of Pediatrics, University of California Irvine School of Medicine, Irvine, CA 92697, USA
1 shared publication - Geetha Puthenveetil
Department of Pediatric Hematology Children's Hospital of Orange County Orange California USA
1 shared publication - Ivan Kirov
Division of Oncology CHOC Children's Hospital Orange CA USA
1 shared publication
Latest Publications
- 7 March 2013
- Published by Wiley in Pediatric Transplantation
- Vol. 17 (3) , E104-E107
Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia
Over 400 cases of pediatric SAA occur annually in the United States. A growing number of children with SAA may have had their stem cells harvested through cord blood collection. We describe a nine‐yr‐old male with SAA treated successfully with an autologous cord blood transplant following immunoablative chemotherapy. With the increasing number of people cryopreserving autologous cord blood, the use of autologous cord blood in the treatment of SAA might be considered as initial therapy. This case serves to discuss approaches to preparative therapy as well as the potential complications in this growing cohort of patients.
- 7 March 2013
- Published by Wiley in Pediatric Transplantation
- Vol. 17 (3) , E104-E107
Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia
Over 400 cases of pediatric SAA occur annually in the United States. A growing number of children with SAA may have had their stem cells harvested through cord blood collection. We describe a nine‐yr‐old male with SAA treated successfully with an autologous cord blood transplant following immunoablative chemotherapy. With the increasing number of people cryopreserving autologous cord blood, the use of autologous cord blood in the treatment of SAA might be considered as initial therapy. This case serves to discuss approaches to preparative therapy as well as the potential complications in this growing cohort of patients.